US 11,702,441 B2
Spirobicyclic analogues
Jonas Verhoeven, Brussels (BE); Guido Alfons F. Verniest, Beerse (BE); Johannes Wilhelmus John F. Thuring, Beerse (BE); Tongfei Wu, Hever (BE); Vineet Pande, Beerse (BE); Lieven Meerpoel, Beerse (BE); Dirk Brehmer, Beerse (BE); Weimei Sun, Raritan, NJ (US); and Scott E. Denmark, Champaign, IL (US)
Assigned to Janssen Pharmaceutica NV, Beerse (BE)
Filed by Janssen Pharmaceutica NV, Beerse (BE)
Filed on Jun. 10, 2021, as Appl. No. 17/344,261.
Application 17/344,261 is a continuation of application No. 16/769,793, granted, now 11,059,850, previously published as PCT/EP2018/083808, filed on Dec. 6, 2018.
Claims priority of provisional application 62/596,441, filed on Dec. 8, 2017.
Claims priority of application No. 18163867 (EP), filed on Mar. 26, 2018.
Prior Publication US 2021/0380627 A1, Dec. 9, 2021
Int. Cl. C07H 19/167 (2006.01)
CPC C07H 19/167 (2013.01) 2 Claims
 
1. A compound that is any one of the following:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
and the pharmaceutically acceptable addition salts, and solvates thereof.